Prediction of MicroRNAs in the Epstein–Barr Virus Reveals Potential Targets for the Viral Self-Regulation
- 95 Downloads
Studies involving miRNAs have opened discussions about their broad participation in viral infections. Regarding the Human gammaherpesvirus 4 or Epstein–Barr virus (EBV), miRNAs are important regulators of viral and cellular gene expression during the infectious process, promoting viral persistence and, in some cases, oncogenic processes. We identified 55 miRNAs of EBV type 2 and inferred the viral mRNA target to self-regulate. This data indicate that gene self-repression is an important strategy for maintenance of the viral latent phase. In addition, a protein network was constructed to establish essential proteins in the self-regulation process. We found ten proteins that work as hubs, highlighting BTRF1 and BSRF1 as the most important proteins in the network. These results open a new way to understand the infection by EBV type 2, where viral genes can be targeted for avoiding oncogenic processes, as well as new therapies to suppress and combat the persistent viral infection.
KeywordsEpstein–Barr virus miRNA s Self-regulation
This work was funded in part by grants from Comisión Nacional de Investigación Científica y Tecnológica (CONICYT), Chile: FONDECYT 10111620, FONDAP 15130011, PAI PAI79170021. ACC received a master degree fellowship from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil. VSS was a post doctorate fellowship from PNPD/CAPES.
- 3.Palser AL, Grayson NE, White RE, Corton C, Correia S, Ba Abdullah MM, Watson SJ, Cotton M, Arrand JR, Murray PG, Allday MJ, Rickinson AB, Young LS, Farrell PJ, Kellam P (2015) Genome diversity of Epstein–Barr virus from multiple tumor types and normal infection. J Virol 89:5222–5237. https://doi.org/10.1128/JVI.03614-14 CrossRefGoogle Scholar
- 8.Skalsky RL, Cullen BR (2010) Viruses, microRNAs, and host interactions. Annu Rev Microbiol 64:123–141. https://doi.org/10.1146/annurev.micro.112408.134243 CrossRefGoogle Scholar
- 14.Denman RB (1993) Using RNAFOLD to predict the activity of small catalytic RNAs. Biotechniques 15:1090–1095Google Scholar
- 28.Mackett M, Conway MJ, Arrand JR, Haddad RS, Hutt-Fletcher LM (1990) Characterization and expression of a glycoprotein encoded by the Epstein–Barr virus BamHI I fragment. J Virol 64:2545–2552Google Scholar
- 30.Kawashima D, Kanda T, Murata T, Saito S, Sugimoto A, Narita Y, Tsurumi T (2013) Nuclear transport of Epstein–Barr virus DNA polymerase is dependent on the BMRF1 polymerase processivity factor and molecular chaperone Hsp90. J Virol 87:6482–6491. https://doi.org/10.1128/JVI.03428-12 CrossRefGoogle Scholar
- 37.Gustafson EA, Chillemi AC, Sage DR, Fingeroth JD (1998) The Epstein–Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase. Antimicrob Agents Chemother 42:2923–2931CrossRefGoogle Scholar
- 42.Van Gent M, Braem SGE, de Jong A, Delagic N, Peeters JGC, Boer IGJ, Moynagh PN, Kremmer E, Wiertz EJ, Ovaa H, Griffin BD, Ressing ME (2014) Epstein–Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling. PLoS Pathog 10:e1003960. https://doi.org/10.1371/journal.ppat.1003960 CrossRefGoogle Scholar